CRDF Cardiff Oncology, Inc.
$0.88▲ +8.80%
Healthcare
Other
After hours
$0.88▲ +0.56%
Oct 27, 5:25 PM ET
Volume 637.0K
Avg Volume (10D) 461.4K
Key Metrics & Fundamentals
Market Cap
$68.08M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.76 - 3.31
% vs 50 MA
-18.99%
% vs 200 MA
-40.32%
RSI-14
36.4
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.75
Free Cash Flow
-$11.81M
Gross Rev
$104,000
Gross Profit
$104,000
EBITDA
-$9.62M
COGS
–
Operating Exp
$9.72M
Operating Income
-$9.62M
EBIT
-$9.62M
Pretax Income
-$9.23M
Net Income
-$9.23M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer
GlobeNewswire · Oct 27, 2026 4:05 PM ET
Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
GlobeNewswire · Oct 21, 2026 4:05 PM ET
3 Clinical-Stage Cancer Stocks With Pristine Balance Sheets
Simply Wall St. · Sep 15, 2026 10:51 PM ET
Cardiff Oncology Shares Rise After Upgrade From HC Wainwright
MT Newswires · Sep 15, 2026 2:55 PM ET
HC Wainwright Upgrades Cardiff Oncology to Buy From Neutral, Price Target is $9
MT Newswires · Sep 15, 2026 6:32 AM ET
Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement
GlobeNewswire · Sep 14, 2026 8:30 AM ET
Cardiff Oncology to Participate in September 2026 Conferences
GlobeNewswire · Sep 2, 2026 7:00 AM ET
CRDF: Second Quarter Earnings
Zacks Small Cap Research · Aug 17, 2026 5:47 AM ET
William Blair Downgrades Cardiff Oncology to Market Perform From Outperform
MT Newswires · Aug 12, 2026 7:34 AM ET
Cardiff Oncology: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 4:46 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CRDF's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.